Alkem Laboratories Ltd has approved the transfer of its trade generics business to its subsidiary Alkem Wellness Ltd for a minimum consideration of Rs. 750 crores, effective by March 31, 2025. This trade generics business generated revenue of about Rs. 1,783.8 crores in FY 2023-2024.